Pharmaceuticals Packing & Labeling Services in the US - Industry Research Report

En route: Rising e-commerce sales and increased regulatory oversight will benefit packaging and labeling services

Pharmaceuticals Packing and Labeling Service companies handle the outsourced need for packing and labeling services for pharmaceutical companies looking to get their new products on the market. These companies need to outsource their services to packaging and labeling companies due to the very strict regulations from the FDA and other US regulatory watchdogs. Shifting age demographic have also provided strong downstream demand for industry services. The number of adults aged 65 and older is expected to grow through 2023, pushing more consumers into a riskier age of their life. The older Americans get, the more at risk they are for illnesses that require medical intervention. As a result, more prescriptions and medical devices will need packaging and labeling. Overall, revenue for Pharmaceutical Packaging and Labeling Services is expected to grow at a CAGR of 5.0% to $602.9 million through the period, with a 3.8% increase in 2023 alone, when profit is set to reach 4.9%.

This industry provides packing and labeling services for prescription and over-the-counter pharmaceuticals, biologics, consumer health and veterinary products. Industry services may include packaging into blisters, bottles, pouches and unit doses, specialty vial or syringe labeling and kitting for injectables. Secondary packaging services (e.g. putting a bottle of tablets into a box, putting blister packs into a carton) are also included in the industry.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.